The Medical Letter on Drugs and Therapeutics
ONLINE
ONLY
ARTICLE
ONLY
ARTICLE
March 24, 2021
Stiripentol (Diacomit) for Dravet Syndrome (online only)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Stiripentol (Diacomit) for Dravet Syndrome (online only)
March 24, 2021 (Issue: 1620)
The FDA has approved stiripentol (Diacomit – Biocodex)
for treatment of seizures in patients ≥2 years old with
Dravet syndrome who are also taking clobazam (Onfi).
Stiripentol, which has been available in Europe, Canada,
and Japan for many...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.